Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5Cholangiocarcinoma 4Colonic Neoplasms 3Neoplasm Metastasis 2Jaundice 2Gallbladder Neoplasms 2Bites and Stings 2Bile Duct Neoplasms 2Urologic Diseases 1Urolithiasis 1Urinary Calculi 1Ureterolithiasis 1Ureteral Obstruction 1Stent Occlusion 1Renal Insufficiency 1Rectal Neoplasms 1Pyonephrosis 1Pyelonephritis 1Nephrolithiasis 1Kidney Diseases 1Kidney Calculi 1Infections 1Hydronephrosis 1Head and Neck Neoplasms 1HCC 1Fistula 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Stents × Clear all
NCT02971345 2020-06-11

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

Shanghai Zhongshan Hospital

Phase 3 Unknown
253 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡